Personal injury law firms are actively investigating claims on behalf of patients who took blood pressure medication containing valsartan and were later diagnosed with liver damage, tumors, or cancer. Patients who received blood pressure medication containing Valsartan may have legal recourse against the drug manufacturer and will be needing legal representation.
Law firms can connect with victims of Valsartan injuries by contacting Broughton Partners, a case generation and legal marketing firm that wants to help attorneys find only quality Valsartan cases. Patients who have suffered harmful side effects after taking Valsartan will be looking for a drug injury law firm for legal assistance. Broughton Partners connects personal injury law firms with Valsartan lawsuit leads and other drug injury leads. The leads we deliver to law firms are case-ready and pre-qualified. Law firms looking for more Valsartan lawsuit leads can work with Broughton Partners and start receiving Valsartan lawsuit leads that fit their specific case criteria.
What is Valsartan?
Valsartan is an active ingredient in many generic drugs, including drugs used to treat hypertension, heart failure, left ventricular heart failure, and left ventricular heart dysfunction following myocardial infarction.
Valsartan is also prescribed in conjunction with hydrochlorothiazide (HCTZ) to treat hypertension.
Patients Are Filing Valsartan Lawsuits
There have been a series of recalls involving several well-known high blood pressure medications. Some of these medications, offered by different manufacturers, include Losartan, Valsartan, and Irbesartan.
A massive recall came from Aurobindo Pharma USA, who voluntarily recalled over 80 lots of their popular high blood pressure medications, including the following:
- Valsartan HCTZ Tablets
- Amlodipine Valsartan Tablets USP
- Valsartan Tablets USP
Nearly 80 million high blood pressure prescriptions have been written since 2016. Beyond that, many people who have come to rely on these medications are now left scrambling to find alternatives.
Valsartan Recall in 2018
In May 2018, the European Medicines Agency announced its discovery that there existed a potentially dangerous impurity in valsartan medication sourced from Zhejiang Huahai Pharmaceuticals, a Chinese drug manufacturer.
In July 2018, the Food & Drug Administration (FDA) announced a recall for several types of generic valsartan, warning that the manufacturing process of these drugs resulted in impurities including a substance known as N-nitrosodimethylamine (NDMA), which is believed to increase the risk of cancer in animals and humans. NDMA is an organic chemical that is both toxic and carcinogenic, especially when mixed with water. The Environmental Protection Agency (EPA) indicates that the safe limit for human ingestion of NDMA is 96 nanograms. FDA investigations of contaminated valsartan lots demonstrate that the recalled pills exceeded safe levels.
Specific versions of Valsartan and Valsartan HCTZ may include contaminated ingredients, thereby exposing patients to an increased risk of cancer and other serious side effects.
Many valsartan recalls have been announced by the FDA to date, impacting batches sold by many pharmaceutical companies or re-packagers, including:
- Major Pharmaceuticals
- Teva Pharmaceuticals
- Solco Healthcare
- A-S Medication Solutions LLC
- Bryant Ranch Prepack Inc.
- H.J. Harkins Company, Inc.
- Lake Erie Medical, Doing Business As Quality Care Products LLC
- NuCare Pharmaceuticals
- Proficient Rx
The Food and Drug Administration estimates that between 3 million and 3.7 million patients have been prescribed medications containing valsartan each year for a three-year period ending in 2018. According to Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, the FDA has “carefully assessed the valsartan-containing medications sold in the United States, and we’ve found that the valsartan sold by these specific companies does not meet our safety standards. This is why we’ve asked these companies to take immediate action to protect patients”. With this FDA action, the United States joins 22 other countries that have taken action involving valsartan.
The FDA’s press releases have unequivocally linked the presence of NDMA in valsartan to an error in the manufacturing process, stating that “the presence of NDMA [in valsartan] was unexpected and is thought to be related to changes in the way the active substance was manufactured.” As a result, the FDA is conducting a full-scale, comprehensive investigation into the safety of the recalled products.
The FDA’s online adverse events reporting system indicates that there have been more than 19,000 severe reports, including more than 2,800 deaths, related to valsartan injuries dating back to 2009.
The FDA cautions patients against stopping the use of valsartan products “cold turkey” without first garnering advice from their doctor, as an abrupt stopping of the drug can cause severe adverse effects.
Valsartan History: Recalls & Warnings
November 2018 – Various lots of Valsartan are recalled due to contamination with NDMA, NDEA, and/or NMBA. Teva Pharmaceuticals removes all amlodipine/valsartan combination tablets and amlodipine/valsartan/hydrochlorothiazide combination tablets after NDEA contamination was found.
August 2018 – Torrent Pharmaceuticals recalls 14 lots of Valsartan/Amlodipine/HCTZ tablets due to NDMA contamination.
August 2018 – Camber Pharmaceuticals recalls specific batches of Valsartan contaminated with NDMA.
July 2018 – The FDA announces that 3 manufacturers will be voluntarily recalling their dangerous drugs that contain Valsartan. The FDA also provides regulations and guidance on how to properly test Valsartan for any contamination.
May 2018 – The European Medicines Agency (EMA) reviews medications containing Valsartan that were supplied by Zhejiang Huahai Pharmaceuticals. The EMA’s review started after the company detected NDMA in the medication it was supplying to European Union manufacturers.
What Are Common Side Effects of Valsartan?
Before prescribing valsartan, a doctor has judged that the benefit to the patient outweighs the risk of side effects. Common side effects that may occur usually require no medical attention and go away without medical treatment include:
- Cold symptoms (sore throat, cough, sneezing, runny or stuffy nose)
- Upper respiratory infection
- Blurred vision
- Difficulty with moving
- Flu symptoms
- Muscle pain or stiffness
- Stomach pain
- Joint pain
- Back pain
- Itching or skin rash
It is common for a person to experience lightheadedness or dizziness when they first begin taking the medication. However, as their body adjusts to valsartan these symptoms usually go away. If they persist or get worse, however, it is essential to speak with a doctor or pharmacist immediately.
What Are Serious Side Effects of Valsartan?
Many people who are prescribed valsartan do not experience serious side effects; however, it is important to monitor one’s health for signs of severe symptoms. Anyone experiencing severe symptoms of blood pressure medications should notify their doctor immediately as it is always better to address serious health concerns sooner rather than later. The serious side effects of Valsartan include:
- Chest Pain
- Shortness of breath
- Muscle weakness
- Increased thirst
- Loss of appetite
- Cold sweats
- Sudden trouble with breathing or swallowing
- Weight loss
- Swelling of the skin, generally around the eyes and lips
Although Valsartan helps many patients with kidney problems, in rare cases it can worsen the condition of the kidneys. Some common signs of kidney problems include blood in urine, decreased frequency or amount of urination, and pain with urination.
What Are the Signs and Symptoms of NDMA Exposure?
Short-term exposure to NDMA can cause liver damage, whereas long-term exposure may also reduce platelet counts in the blood. Long-term ingestion of NDMA may lead to an increased occurrence of tumors in the liver, kidneys or lungs, according to the results of animal studies cited by the EPA.
Potential symptoms of NDMA over-exposure include:
- Abdominal Cramps
- Enlarged Liver
- Reduced Function Of Liver, Kidneys, And Lungs
NDMA-laced Valsartan can also cause or exacerbate symptoms of kidney impairment, which include weight gain and swelling in hands, feet or ankles. The toxins may also increase potassium levels in the blood, which can be problematic for patients with heart or kidney conditions.
Victims of a Valsartan lawsuit may be entitled to compensation for past and future medical bills, lost wages and, their pain and suffering. Broughton Partners works to connect these Valsartan victims and other victims of dangerous drugs with personal injury law firms.
Get Connected With Qualified Valsartan Lawsuit Leads
Victims of Valsartan side effects will begin their search for legal options online and will be looking for drug injury attorneys that can help them. Broughton Partners’ legal case generation services will track Valsartan lawsuit leads as soon as they show interest online and after they call. Our professional intake associates work only to acquire qualified Valsartan lawsuit cases with retained plaintiffs. The in-house call center is staffed 24/7 by highly trained multilingual specialists. Our innovative case-acquisition platform is always being monitored and optimized to track only quality Valsartan leads. We have a hard-working team and an industry-leading case-acquisition platform that allows us to deliver the Valsartan lawsuit leads your law firm wants.
Broughton Partners wants to help your law firm by creating an effective campaign for high-quality Valsartan lawsuit leads and providing you with potential Valsartan cases to increase your revenue. Victims of dangerous drugs such as Valsartan are able to find legal help via our network of websites and targeted online advertising.
Our Valsartan Lawsuit Leads Are Fully Vetted & Signed
Broughton Partners’ goal is to provide law firms with retained Valsartan plaintiffs. However, we don’t stop there. We go further by providing Valsartan lawsuit leads ready with their case documents, such as hospital files and drug history. This way your law firm can save time on and start working the case immediately. The Valsartan lawsuit leads that are provided by Broughton Partners are real victims who have legitimate Valsartan cases.
It can be difficult to find Valsartan lawsuit leads, especially leads that are high-quality with retained plaintiffs. Save your law firm’s time and let us do the tedious work for you by examining potential Valsartan lawsuit leads and delivering only the best cases to your law firm.
Case Criteria for Valsartan Lawsuit Leads
Broughton Partners will only deliver quality Valsartan Lawsuit leads that are pre-qualified and match the case criteria specified by your law firm. Our team of specialists will be examining the eligibility of cases and whether or not a patient’s claim qualifies for a Valsartan lawsuit. The Valsartan lawsuit leads that your law firm will receive will have already been vetted and thoroughly qualified to ensure you are getting the cases you want.
The Valsartan lawsuit leads that Broughton Partners will deliver must meet the following criteria:
- The plaintiff used Valsartan for at least one year in 2014 or later
- After at least one year of taking Valsartan, the plaintiff was diagnosed with:
- Liver Cancer
- Kidney Cancer
- Stomach Cancer
- Intestinal Cancer
- Colon and Rectal Cancer
Broughton Partners Fully Examines All Valsartan Lawsuit Leads
Broughton Partners will only deliver quality Valsartan Lawsuit leads that are pre-qualified and match the case criteria specified by your law firm. Our team of trained specialists will be examining the eligibility of cases and whether or not a patient’s claim qualifies for a Valsartan lawsuit. Our case intake system is built upon unique parameters and algorithms that allow us to dynamically improve case quality and conversion. We do this by running potential plaintiffs through specialized questions and a qualification process based on your law firm’s desired criteria. The Valsartan lawsuit leads that your law firm will receive will be questioned and examined to ensure that they are quality retained plaintiffs.
The Valsartan lawsuit leads that Broughton Partners will deliver must meet the following criteria:
- Potential plaintiffs have suffered from one of the previously mentioned Valsartan side effects as a result of taking Valsartan
- Potential plaintiffs were inadequately warned by Valsartan’s manufacturers about the life-threatening risks of taking Valsartan
Is your law firm looking to represent victims of Valsartan?
Broughton Partners finds victims diagnosed with a harmful health condition caused by Valsartan and are in need of legal help or are actively seeking legal representation. Our legal case generation firm closely partners with your law firm by providing you with retained plaintiffs who are vetted, prequalify and follow your Valsartan injury case criteria. You only receive retained cases that match your needs so you can effectively focus on your current clients’ legal needs and leave case acquisition marketing to us.
Call Broughton Partners today at (855) 463-1735, or contact us for your free consultation. Together we can ensure there is No Claimant without a Claim.
- Charles Patrick Davis, MD, PhD. “Diovan”, RxList, https://www.rxlist.com/diovan-side-effects-drug-center.htm. Accessed May 31, 2019.
- WebMD. “Valsartan”, WebMD, https://www.webmd.com/drugs/2/drug-849/valsartan-oral/details. Accessed May 31, 2019.
- Mayo Clinic. “Valsartan (Oral Route)”, Mayo Clinic, https://www.mayoclinic.org/drugs-supplements/valsartan-oral-route/side-effects/drg-20067355. Accessed May 31, 2019.
- Jacqueline Howard. “Valsartan recall: 4 things patients should know”, CNN, https://www.cnn.com/2018/07/19/health/valsartan-recall-explainer/index.html. Accessed May 31, 2019.
- Memorial Sloan Kettering Cancer Center. “Valsartan and Hydrochlorothiazide”, Wolters Kluwer Clinical Drug Information, Inc, https://www.mskcc.org/cancer-care/patient-education/valsartan-and-hydrochlorothiazide. Accessed May 31, 2019.
- Megan Trimble. “Blood Pressure Medicine Recalled Over Cancer Concern”, U.S. News, https://www.usnews.com/news/national-news/articles/2019-01-02/blood-pressure-medicine-valsartan-recalled-over-cancer-concern. Accessed May 31, 2019.